COPD patients with more severe GOLD stages have higher serum cystatin C levels Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Relationship between blood eosinophil levels and severity of COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Blood eosinophil counts in COPD patients compared to controls Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019 Year: 2019
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018 Year: 2018
Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Elevation of plasma cystatin C levels in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002
Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
High eosinophil counts predict decline in FEV1 : results from the CanCOLD study Source: Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020 Year: 2021
Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016
Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015
Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016
Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020
Dynamics of marker of inflammation - sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients. Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021